TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2022

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2022

  • Category:Life Sciences
  • Published on : 26 October 2022
  • Pages :89
  • Formats:
  • Report Code:SMR-7461661
OfferClick for best price

Best Price: $2320

NonSteroidal AntiInflammatory Drugs NSAIDs Market Size, Share 2022


Market Analysis and Insights: Global NonSteroidal AntiInflammatory Drugs NSAIDs Market

The global NonSteroidal AntiInflammatory Drugs NSAIDs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NonSteroidal AntiInflammatory Drugs NSAIDs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NonSteroidal AntiInflammatory Drugs NSAIDs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NonSteroidal AntiInflammatory Drugs NSAIDs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NonSteroidal AntiInflammatory Drugs NSAIDs market.

Global NonSteroidal AntiInflammatory Drugs NSAIDs Scope and Market Size

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Aspirin

Ibuprofen

Naproxen

Celecoxib

Others

Segment by Application

Drug Store

Hospital Pharmacies

Online

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Roche (Genentech)

Amgen

B-MS

Merck

Pfizer

Novartis

Eli Lilly and Company

Johnson & Johnson

GSK

Sanofi

Boehringer Ingelheim

Zhejiang Jiuzhou Pharmaceutical

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes NonSteroidal AntiInflammatory Drugs NSAIDs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of NonSteroidal AntiInflammatory Drugs NSAIDs, with price, sales, revenue, and global market share of NonSteroidal AntiInflammatory Drugs NSAIDs from 2019 to 2022.

Chapter 3, the NonSteroidal AntiInflammatory Drugs NSAIDs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the NonSteroidal AntiInflammatory Drugs NSAIDs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the NonSteroidal AntiInflammatory Drugs NSAIDs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of NonSteroidal AntiInflammatory Drugs NSAIDs.

Chapter 13, 14, and 15, to describe NonSteroidal AntiInflammatory Drugs NSAIDs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 NonSteroidal AntiInflammatory Drugs NSAIDs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 89 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Celecoxib
1.2.6 Others
1.3 Market by Application
1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2017-2028)
2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Region
2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2017-2022)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2023-2028)
2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
2.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
2.3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue
3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2017-2022)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2017-2022)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2021
3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.6 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.7 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2017-2022)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2023-2028)
5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2017-2022)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
9.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
9.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche (Genentech)
11.1.1 Roche (Genentech) Company Detail
11.1.2 Roche (Genentech) Business Overview
11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.1.5 Roche (Genentech) Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.2.5 Amgen Recent Development
11.3 B-MS
11.3.1 B-MS Company Detail
11.3.2 B-MS Business Overview
11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.3.5 B-MS Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.6.5 Novartis Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Detail
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.7.5 Eli Lilly and Company Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Detail
11.9.2 GSK Business Overview
11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.9.5 GSK Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.10.5 Sanofi Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Detail
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Detail
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Aspirin
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Naproxen
Table 5. Key Players of Celecoxib
Table 6. Key Players of Others
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2017-2022)
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2023-2028)
Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2017-2022)
Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2021)
Table 20. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 24. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2017-2022)
Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2023-2028)
Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2017-2022)
Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2023-2028)
Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 44. Roche (Genentech) Company Detail
Table 45. Roche (Genentech) Business Overview
Table 46. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 47. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 48. Roche (Genentech) Recent Development
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 52. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. B-MS Company Detail
Table 55. B-MS Business Overview
Table 56. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 57. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 58. B-MS Recent Development
Table 59. Merck Company Detail
Table 60. Merck Business Overview
Table 61. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 62. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 63. Merck Recent Development
Table 64. Pfizer Company Detail
Table 65. Pfizer Business Overview
Table 66. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 67. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 72. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Eli Lilly and Company Company Detail
Table 75. Eli Lilly and Company Business Overview
Table 76. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 77. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 78. Eli Lilly and Company Recent Development
Table 79. Johnson & Johnson Company Detail
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 82. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. GSK Company Detail
Table 85. GSK Business Overview
Table 86. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 87. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 88. GSK Recent Development
Table 89. Sanofi Company Detail
Table 90. Sanofi Business Overview
Table 91. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 92. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 93. Sanofi Recent Development
Table 94. Boehringer Ingelheim Company Detail
Table 95. Boehringer Ingelheim Business Overview
Table 96. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)Product
Table 97. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 98. Boehringer Ingelheim Recent Development
Table 99. Zhejiang Jiuzhou Pharmaceutical Company Detail
Table 100. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 101. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)Product
Table 102. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 103. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2021 VS 2028
Figure 2. Aspirin Features
Figure 3. Ibuprofen Features
Figure 4. Naproxen Features
Figure 5. Celecoxib Features
Figure 6. Others Features
Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2021 & 2028
Figure 8. Drug Store Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Case Studies
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2021 VS 2028
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2021
Figure 16. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2021
Figure 18. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 20. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 24. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2017-2028)
Figure 32. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 40. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 44. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 47. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 48. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 49. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 50. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 51. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 53. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 54. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 55. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 57. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount